levofloxacin has been researched along with Eye Infections, Parasitic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boonmars, T; Laummaunwai, P; Sanpool, O; Thongseesuksai, T; Wongwai, P | 1 |
| Ehara, T; Fujita, K; Goto, H; Hattori, T; Koike, N; Kumakura, S; Kuroda, M; Matsumoto, T; Nakagawa, H; Takahashi, H | 1 |
| Ehara, T; Goto, H; Hattori, T; Koike, N; Kumakura, S; Matsumoto, T; Nakagawa, H; Narimatsu, A | 1 |
| Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
4 other study(ies) available for levofloxacin and Eye Infections, Parasitic
| Article | Year |
|---|---|
Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts.
Topics: Acanthamoeba; Amebiasis; Animals; Eye Infections, Parasitic; Gatifloxacin; Gentamicins; Humans; Levofloxacin; Ophthalmic Solutions | 2020 |
Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Bacterial Agents; Bacterial Physiological Phenomena; Disease Models, Animal; DNA, Bacterial; DNA, Protozoan; Escherichia coli; Eye Infections, Parasitic; Fluorescent Dyes; Humans; Levofloxacin; Microscopy, Electron; Organic Chemicals; Rabbits; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 18S | 2015 |
Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Physiological Phenomena; Disease Models, Animal; Eye Infections, Parasitic; Levofloxacin; Pseudomonas aeruginosa; Rabbits; Time Factors | 2017 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |